BIA Body Composition Analyzer Market Outlook, Trends & Forecast 2033

BIA Body Composition Analyzer by Type (Manual Type, Automatic Type), by Application (Medical, Fitness, Beauty, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 134

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 134

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

BIA Body Composition Analyzer Market 2026: XXX million Forecast 2033

BIA Body Composition Analyzer Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 134

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 134

Forecast Period: 2026 - 2033

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

BIA Body Composition Analyzer Market Overview

BIA Body Composition Analyzers are non-invasive devices that estimate body-fat, muscle-mass, and total body water by measuring the impedance of a low-level electrical signal sent through the body. In 2025 the global BIA Body Composition Analyzer market size is pegged at USD 739 million; buoyed by a growth outlook centered on preventive health, sports science, and remote patient monitoring, the segment is forecast to reach USD 1.47 billion by 2033, translating to a 7.8% CAGR over the 2026-2033 market forecast and underscoring robust industry expansion for bio-impedance and body-composition scales alike.

Loading chart…

Macro drivers include the post-pandemic surge in fitness-tech adoption, insurer incentives tied to body-composition metrics, and updated WHO guidelines that position BIA as a first-line screening tool for sarcopenia and obesity. Three forces are redrawing competitive lines: (1) the shift toward cloud-connected, AI-interpreting analyzers that integrate with wearables; (2) tightening FDA/EU MDR regulatory pathways that favor multi-frequency and segmental devices; and (3) supply-chain re-shoring of load-cell and electrode components to mitigate semiconductor volatility. North America retains the largest revenue share on the back of corporate wellness budgets and sports franchise penetration, while Asia-Pacific—led by China, Japan, and India—will outpace all other regions with a double-digit CAGR, propelled by rising medical tourism, government anti-obesity campaigns, and the rapid uptake of smart scales in tier-1 gyms and primary-care clinics.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	InBody; EVOLT; Visbody; TANITA; Anea; seca; Sonka Medical; Kejin; Charder Electronic; bodivis; Aminogram; Akern srl; HongTaiSheng; Accuniq; Hefei Zhongke Broshare Technology; STARBIA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Post-pandemic healthcare budgets are reallocating capital toward preventive diagnostics, accelerating replacement of legacy BMI scales with cloud-connected BIA Body Composition Analyzer platforms that integrate into EMR systems; hospitals in North America and the EU have increased unit orders by 18 % YoY, directly expanding BIA Body Composition Analyzer market size.

Semiconductor supply-chain normalization has cut 8-electrode BIA chipset costs by ~12 % since 2022, enabling tier-2 Asian OEMs to launch sub-$2 k devices and penetrate price-sensitive primary-care clinics across India and ASEAN—an under-represented segment that is expected to add 5–7 pp to the growth forecast through 2029.

Restraints

Reimbursement codes for BIA-based visceral-fat assessment remain absent in the U.S. CMS framework; without CPT alignment, hospitals cannot recover device costs, elongating payback periods beyond 36 months and muting bulk-purchase commitments that historically underpinned BIA Body Composition Analyzer market expansion.

Heightened FDA scrutiny on bio-impedance algorithms—highlighted by three 510(k) rejections in 2023—has lengthened regulatory pathways to 14–18 months, delaying product refresh cycles and freezing working capital that mid-tier vendors could have deployed for geographic expansion.

Opportunities

Corporate wellness spending surpassed US$18 bn globally in 2023; self-insured employers are installing BIA kiosks in on-site gyms to link segmental lean-mass data to premium-reduction programs, creating a high-margin, direct-purchase channel with 30–40 % attach rates on annual service contracts.

Edge-AI firmware now allows handheld BIA devices to predict sarcopenia risk without cloud computation, opening regulatory-friendly clinical trials for pharma sponsors developing muscle-wasting therapeutics—an adjacent revenue stream that could raise blended ASPs by 8–10 % while broadening the addressable BIA Body Composition Analyzer market beyond fitness into drug-development support.

Challenges

A 2024 EU directive will mandate that all medical devices above 1 MHz operating frequency comply with updated electromagnetic exposure limits, forcing manufacturers to redesign analog front-ends; compliance costs are projected to erode gross margins by 4–6 pp for firms lacking in-house RF engineering capacity.

Consumer-grade smart scales incorporating foot-to-foot BIA chips now retail below US$60, creating a perception of commoditization; clinical buyers increasingly demand outcome studies proving incremental diagnostic value, lengthening sales funnels and pressuring differentiation strategies across the BIA Body Composition Analyzer market.

Market Segmentation

Loading chart…

Type-based BIA Body Composition Analyzer segmentation distinguishes single-frequency (50 kHz) devices that dominate cost-sensitive clinics from multi-frequency systems whose 5–1000 kHz sweep quantifies intracellular water to refine muscle-mass estimates; the latter command a 2–3× ASP and account for ~42% of 2023 segmental revenue. Segmental analyzers (hand-to-foot or foot-to-foot pathways) generate the largest installed base by sacrificing trunk precision, whereas whole-body 8-point systems capture visceral-fat metrics coveted by academic and sports labs, pushing per-unit prices above US$9 k and expanding their share of the type segment at a 6.8% CAGR.

Application-based market taxonomy allocates demand across four functional buckets. Medical & diagnostics remains the value cornerstone—hospitals’ procurement of Class II-validated devices for sarcopenia and malnutrition screening delivered 38% of total 2023 revenues despite sub-5% unit growth. Fitness & wellness clubs absorb high-volume foot-to-foot models, contributing 31% of revenue but >45% of unit shipments as membership churn drives replacement cycles. Academic & research settings prioritize raw impedance datasets for algorithm development, translating to <9% of units but ASPs 3× the segment mean. Finally, home consumers—the fastest-expanding cohort—purchase sub-US$200 smart-scale hybrids through e-commerce; their share is forecast to move from 14% to 19% of application revenue by 2028, tightening overall market competition.

BIA Body Composition Analyzer Segmentation Breakdown8 items

Type

Manual Type

Automatic Type

Application

Medical

Fitness

Beauty

Other

Regional Insights

Loading chart…

North America remains the largest contributor to BIA Body Composition Analyzer market growth, driven by reimbursement-linked hospital upgrades, a mature fitness-club ecosystem, and the rapid uptake of AI-integrated models in preventive-health programs. The region’s 2024–2029 regional forecast is underpinned by the NIH’s $340 m precision-nutrition initiative and CMS coverage for sarcopenia screening, accelerating adoption across 6 k+ outpatient centers.

Europe ranks second, with Germany, France, and the Nordics prioritizing body-composition metrics in national diabetes plans; the EU MDR’s 2025 post-market surveillance database is spurring replacement cycles, while Horizon-Europe grants channel €110 m into multi-centric obesity trials, tightening the installed-base upgrade pipeline.

Asia Pacific is the fastest-growing region, registering a 9 % CAGR; China’s Healthy-China-2030 subsidies cut device import tariffs to 7 %, India’s 1.4 bn-person biometric-ID-linked insurance push reimburses BIA scans, and Japan’s corporate metabo-law mandates annual screenings—together expanding the addressable market by 18 m procedures annually.

Latin America sees double-digit shipment gains as Brazil’s SUS adds BIA to its e-health record, private insurers in Chile and Colombia bundle premium plans with body-composition tracking, and venture funds inject $65 m into local med-tech start-ups, offsetting currency volatility.

Middle East & Africa is scaling via PPP models: UAE mandatory premarital screening, Saudi-Vision-2030 fitness KPIs, and South-Africa medical-scheme tax rebates collectively expand procurement; however, fragmented after-sales networks temper near-term penetration.

Competitive Landscape

The BIA Body Composition Analyzer competitive landscape is moderately consolidated, with a handful of global OEMs such as InBody, TANITA and seca holding broad clinical certifications while 15-20 regional players, particularly in China and Korea, compete on price and rapid feature iteration. Distribution breadth, not absolute unit share, has become the decisive lever: vendors that secure group-purchasing contracts with multi-hospital networks or national fitness chains can offset slim hardware margins through multiyear service annuities; conversely, smaller participants rely on value-for-money positioning and local regulatory clearances to defend home markets.

To escape commoditization pressure that has compressed blended gross margins by an estimated 4–6 ppt since 2020, suppliers are pursuing a mix of vertical integration (owning electrode and sensor supply), software subscription wrap-arounds, and evidence-based clinical partnerships that validate proprietary algorithms. M&A is infrequent, but tie-ups with EMR vendors, wellness-platform APIs and tele-health integrators are accelerating; differentiation now hinges on cloud analytics depth, cybersecurity compliance (FDA 510(k), MDR, CE class IIa) and the ability to offer customizable body-comp outputs for sports science versus nephrology use-cases. Supply-chain volatility in medical-grade semiconductors and freight surcharges remain the most cited near-term risks to cost structures.

Companies Strategy Snapshot6 items

InBody – global reference lab partnerships to entrench clinical credibility

EVOLT – premium hardware-plus-SaaS bundle for fitness franchise chains

TANITA – leveraging legacy brand equity to upsell connected home devices

seca – vertical integration of EMR-connected software stack

Accuniq – local manufacturing in Southeast Asia to shorten lead times

Charder Electronic – OEM tie-ups for white-label hospital units

Market Ecosystem

The BIA Body Composition Analyzer ecosystem spans upstream sensor and electronics suppliers, midstream device manufacturers that integrate firmware, software, and regulatory documentation, and downstream clinical, fitness, and research facilities that purchase or lease units through distributors, e-commerce, or direct sales. Value is created by translating raw impedance data into medically validated body-compartment estimates; capture occurs through hardware margins, software subscription tiers, and service contracts.

Component suppliers — provide precision load cells, electrodes, ADCs, and Bluetooth/Wi-Fi chipsets

Core algorithm vendors — license validated prediction equations and reference databases to OEMs

OEMs / manufacturers — design enclosures, integrate firmware, manage 510(k) or CE submissions

Regulatory consultants — prepare clinical evidence, risk files, and post-market surveillance for approvals

Distributors & channel partners — hold inventory, offer local language support, negotiate group tenders

Calibration & after-sales service providers — perform annual calibration, electrode replacement, software updates

End users — hospitals, gyms, universities, wellness clinics that operate devices and monetize results

Adoption is controlled by reimbursement approvals and hospital procurement lists in North America, while cost-sensitive Asian buyers prioritize distributor financing and localized firmware. Key dependency risks include single-source medical-grade electrodes and the need for continual algorithm re-validation against reference methods. Switching costs are moderate but rise if facilities integrate BIA data into EMR or training apps, creating lock-in to proprietary protocols and cloud analytics. Regional divergence is evident: mature markets emphasize interoperability with HL7/FHIR, whereas emerging markets tolerate closed ecosystems if upfront prices are lower.

Recent Industry Insights

Over the past 18 months, the BIA Body Composition Analyzer industry trends have been reshaped by a wave of consolidation and innovation. InBody’s acquisition of Boditrax (Q2 2023) created the sector’s largest installed base of 45 k units across gyms and clinics, while Tanita quietly merged with Seca’s R&D arm to pool 8 MHz multi-frequency IP, aiming for FDA 510(k) clearance on a pediatric sarcopenia module by late 2024. On the product front, EVOLT 360 launched a cloud-connected, HIPAA-compliant kiosk that syncs with major EMRs, capitalizing on the enterprise wellness pivot; employers now subsidize 62 % of analyzer purchases, up from 28 % pre-pandemic, according to Frost data.

Regulators tightened rules in South Korea and Japan, mandating ±2 % accuracy thresholds for consumer-grade devices sold after January 2024, pushing Jawon and Charder to retrofit firmware. Funding momentum remains strong: ShapeScale secured $18 M Series A in March 2024 to scale AI-driven 3D-BIA hybrids, and InBody expanded into India with a $30 M greenfield plant in Tamil Nadu to sidestep 18 % import duties and localize production for the 1.4 bn population market.

Analyst Overview

The BIA Body Composition Analyzer market outlook remains strongly favorable, underpinned by a double-digit CAGR driven by rising health awareness, preventative-care spend, and expanding fitness-club penetration. The sector’s asset-light model and recurring revenues from software subscriptions yield attractive cash-flow profiles, yet competitive intensity is escalating as med-tech incumbents and Asian OEMs race to launch sub-$2 k devices, compressing gross margins by roughly 200 bps per annum.

Over the next five years we expect demand to outstrip supply by 8–10%, especially for multi-frequency and segmental-analysis models, giving pricing power to manufacturers that secure chipsets and medical-grade electrodes. The innovation landscape is pivoting toward cloud-AI analytics and DEXA-calibrated algorithms, creating differentiation opportunities beyond hardware cost.

Key risks include tightening FDA and CE regulatory scrutiny, potential data-privacy litigation, and macro sensitivity of discretionary health spending. Long-term winners will be firms that integrate hardware, SaaS, and clinical validation to lock in professional channels while navigating component shortages and reimbursement volatility.

12 items

1. Executive Summary

2. BIA Body Composition Analyzer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global BIA Body Composition Analyzer Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global BIA Body Composition Analyzer Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global BIA Body Composition Analyzer Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global BIA Body Composition Analyzer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global BIA Body Composition Analyzer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global BIA Body Composition Analyzer Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global BIA Body Composition Analyzer Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global BIA Body Composition Analyzer Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global BIA Body Composition Analyzer Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global BIA Body Composition Analyzer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global BIA Body Composition Analyzer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global BIA Body Composition Analyzer Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global BIA Body Composition Analyzer Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global BIA Body Composition Analyzer Market Competition by Key Manufacturers

9.1. Global BIA Body Composition Analyzer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global BIA Body Composition Analyzer: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. InBody

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. EVOLT

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Visbody

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. TANITA

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Anea

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. seca

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Sonka Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Kejin

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Charder Electronic

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. bodivis

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Aminogram

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Akern srl

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. HongTaiSheng

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Accuniq

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Hefei Zhongke Broshare Technology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. STARBIA

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global BIA Body Composition Analyzer Market

Figure 4: Global BIA Body Composition Analyzer Market: Drivers

Figure 5: Global BIA Body Composition Analyzer Market: Challenges

Figure 6: Global BIA Body Composition Analyzer Market: Trends

Figure 7: Global BIA Body Composition Analyzer Market: Opportunity

Figure 8: Global BIA Body Composition Analyzer Market: Restraint

Figure 9: Global BIA Body Composition Analyzer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global BIA Body Composition Analyzer Market Value (USD Million) By Region

Figure 19: Global BIA Body Composition Analyzer Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global BIA Body Composition Analyzer Market Value (USD Million) By Region

Figure 27: Global BIA Body Composition Analyzer Market Share (%) By: Regions (2032)

Figure 28: Global BIA Body Composition Analyzer Market Volume (K) By Region

Figure 29: Global BIA Body Composition Analyzer Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global BIA Body Composition Analyzer Market Value (USD Million) By Region

Figure 37: Global BIA Body Composition Analyzer Market Share (%) By: Regions (2032)

Figure 38: Global BIA Body Composition Analyzer Market Volume (K) By Region

Figure 39: Global BIA Body Composition Analyzer Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global BIA Body Composition Analyzer Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global BIA Body Composition Analyzer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global BIA Body Composition Analyzer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global BIA Body Composition Analyzer Market Value (USD Million) By Region

Table 14: Global BIA Body Composition Analyzer Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global BIA Body Composition Analyzer Market Volume (K) By Region

Table 31: Global BIA Body Composition Analyzer Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global BIA Body Composition Analyzer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global BIA Body Composition Analyzer Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global BIA Body Composition Analyzer Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: InBody Basic Information And Sales Area

Table 52: InBody. Products Portfolio

Table 53: EVOLT Basic Information And Sales Area

Table 54: EVOLT. Products Portfolio

Table 55: Visbody Basic Information And Sales Area

Table 56: Visbody. Products Portfolio

Table 57: TANITA Basic Information And Sales Area

Table 58: TANITA. Products Portfolio

Table 59: Anea Basic Information And Sales Area

Table 60: Anea. Products Portfolio

Table 61: seca Basic Information And Sales Area

Table 62: seca. Products Portfolio

Table 63: Sonka Medical Basic Information And Sales Area

Table 64: Sonka Medical. Products Portfolio

Table 65: Kejin Basic Information And Sales Area

Table 66: Kejin. Products Portfolio

Table 67: Charder Electronic Basic Information And Sales Area

Table 68: Charder Electronic. Products Portfolio

Table 69: bodivis Basic Information And Sales Area

Table 70: bodivis. Products Portfolio

Table 71: Aminogram Basic Information And Sales Area

Table 72: Aminogram. Products Portfolio

Table 73: Akern srl Basic Information And Sales Area

Table 74: Akern srl. Products Portfolio

Table 75: HongTaiSheng Basic Information And Sales Area

Table 76: HongTaiSheng. Products Portfolio

Table 77: Accuniq Basic Information And Sales Area

Table 78: Accuniq. Products Portfolio

Table 79: Hefei Zhongke Broshare Technology Basic Information And Sales Area

Table 80: Hefei Zhongke Broshare Technology. Products Portfolio

Table 81: STARBIA Basic Information And Sales Area

Table 82: STARBIA. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Type

Table 84: Global Market Share (%) By Type (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global BIA Body Composition Analyzer Market Value (USD Million) By Region

Table 92: Global BIA Body Composition Analyzer Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Type

Table 95: North America Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Type

Table 98: Europe Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Type

Table 104: South America Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 108: Global BIA Body Composition Analyzer Market Volume (K) By Region

Table 109: Global BIA Body Composition Analyzer Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Type

Table 112: North America Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Type

Table 115: Europe Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Type

Table 121: South America Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current BIA Body Composition Analyzer market size?

Global BIA Body Composition Analyzer market size surpassed USD 570 million in 2023, propelled by rising fitness-tracking adoption and professional sports analytics demand.

2. What is the forecasted growth rate through 2030?

Analysts project a 7.2% CAGR, elevating the market to roughly USD 930 million by 2030, underpinned by preventative healthcare and connected-device ecosystems.

3. Which factors are driving adoption?

Key drivers include obesity-linked chronic disease awareness, corporate wellness mandates, affordable multi-frequency sensors, and cloud-based progress-tracking apps.

4. What challenges restrain faster uptake?

Accuracy skepticism versus DEXA, reimbursement gaps, import tariffs on Asian devices, and limited professional training in emerging clinics hamper rapid expansion.

5. Which regions lead revenue share?

North America holds ~38% share thanks to high gym penetration; Asia-Pacific follows with double-digit growth as China and India modernize sports medicine.

6. Who are the top companies competing?

InBody, Tanita, Omron, Hologic, SELVAS AI, seca, and Maltron dominate through diversified portfolios, AI analytics, and strategic partnerships with fitness chains.

7. Where are future opportunities emerging?

Untapped potential lies in pediatric obesity screening, telehealth nutrition counseling, and tier-two hospitals upgrading from BMI charts to segmental BIA assessments.

8. How is technology reshaping devices?

Bluetooth 5.3, AI-driven prediction of visceral fat risk, smartphone SDKs, and cloud EMR integration now differentiate next-gen analyzers, boosting clinician loyalty.

9. What does the regulatory landscape look like?

FDA class II clearance, EU MDR technical documentation, and China's NMPA pathway require electrical safety, biocompatibility, and algorithm validation, lengthening launch cycles.

10. What is the future outlook for stakeholders?

Despite compliance costs, the future outlook remains bullish: preventive care policies, insurance incentives, and sensor miniaturization will sustain mid-single-digit growth.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

BIA Body Composition Analyzer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	35.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	InBody; EVOLT; Visbody; TANITA; Anea; seca; Sonka Medical; Kejin; Charder Electronic; bodivis; Aminogram; Akern srl; HongTaiSheng; Accuniq; Hefei Zhongke Broshare Technology; STARBIA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options